Imaging and diagnostic advances for intracranial meningiomas.

The archetypal imaging characteristics of meningiomas are among the most stereotypic of all central nervous system (CNS) tumors. In the era of plain film and ventriculography, imaging was only performed if a mass was suspected, and their results were more suggestive than definitive. Following more than a century of technological development, we can now rely on imaging to non-invasively diagnose meningioma with great confidence and precisely delineate the locations of these tumors relative to their surrounding structures to inform treatment planning. Asymptomatic meningiomas may be identified and their growth monitored over time; moreover, imaging routinely serves as an essential tool to survey tumor burden at various stages during the course of treatment, thereby providing guidance on their effectiveness or the need for further intervention. Modern radiological techniques are expanding the power of imaging from tumor detection and monitoring to include extraction of biologic information from advanced analysis of radiological parameters. These contemporary approaches have led to promising attempts to predict tumor grade and, in turn, contribute prognostic data. In this supplement article, we review important current and future aspects of imaging in the diagnosis and management of meningioma, including conventional and advanced imaging techniques using CT, MRI, and nuclear medicine.

[1]  R. Fimmers,et al.  Meningioma assessment: Kinetic parameters in dynamic contrast-enhanced MRI appear independent from microvascular anatomy and VEGF expression. , 2018, Journal of neuroradiology. Journal de neuroradiologie.

[2]  U. Haberkorn,et al.  Influence of 68Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: differential impact of photon and proton radiotherapy , 2018, Radiation oncology.

[3]  Jacob S. Young,et al.  Relationship between tumor location, size, and WHO grade in meningioma. , 2018, Neurosurgical focus.

[4]  Chien-Feng Li,et al.  Prediction of progression in skull base meningiomas: additional benefits of apparent diffusion coefficient value , 2018, Journal of Neuro-Oncology.

[5]  S. Bernard,et al.  Meningioma growth dynamics assessed by radiocarbon retrospective birth dating , 2017, EBioMedicine.

[6]  A. Wienke,et al.  Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 2: ADCmin , 2015, Oncotarget.

[7]  Danny J. J. Wang,et al.  Application of arterial spin labeling perfusion MRI to differentiate benign from malignant intracranial meningiomas. , 2017, European journal of radiology.

[8]  M. Weller,et al.  PET imaging in patients with meningioma—report of the RANO/PET Group , 2017, Neuro-oncology.

[9]  Raymond Y Huang,et al.  Radiographic prediction of meningioma grade by semantic and radiomic features , 2017, PloS one.

[10]  Jeong Hoon Kim,et al.  "Wait-and-See" Strategies for Newly Diagnosed Intracranial Meningiomas Based on the Risk of Future Observation Failure. , 2017, World neurosurgery.

[11]  J. Engh,et al.  Alteration of the Ki-67 Proliferative Index following Surgical Resection with or without Radiation Therapy of Intracranial Meningiomas , 2017, Cureus.

[12]  S. Cha,et al.  Meningioma mimics: five key imaging features to differentiate them from meningiomas. , 2017, Clinical radiology.

[13]  A. Wienke,et al.  Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 1: ADCmean , 2017, Oncotarget.

[14]  T. Santarius,et al.  Correlation of volumetric growth and histological grade in 50 meningiomas , 2017, Acta Neurochirurgica.

[15]  Hongyang Zhao,et al.  The Potential Value of Preoperative MRI Texture and Shape Analysis in Grading Meningiomas: A Preliminary Investigation , 2017, Translational oncology.

[16]  W. Paiva,et al.  Clinical Outcome, Tumor Recurrence, and Causes of Death: A Long-Term Follow-Up of Surgically Treated Meningiomas. , 2017, World neurosurgery.

[17]  M. Reiser,et al.  Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI , 2017, The Journal of Nuclear Medicine.

[18]  M. Cherian,et al.  Comparison of post-contrast 3D-T1-MPRAGE, 3D-T1-SPACE and 3D-T2-FLAIR MR images in evaluation of meningeal abnormalities at 3-T MRI. , 2017, The British journal of radiology.

[19]  Armando Manduca,et al.  Slip interface imaging based on MR‐elastography preoperatively predicts meningioma–brain adhesion , 2017, Journal of magnetic resonance imaging : JMRI.

[20]  Young-Hoon Kim,et al.  A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas. , 2017, Journal of neurosurgery.

[21]  A. Nanda,et al.  Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma. , 2017, Journal of neurosurgery.

[22]  Se Hoon Kim,et al.  Amide proton transfer imaging for differentiation of benign and atypical meningiomas , 2017, European Radiology.

[23]  T. Santarius,et al.  Volumetric growth rates of meningioma and its correlation with histological diagnosis and clinical outcome: a systematic review , 2017, Acta Neurochirurgica.

[24]  R. Jain,et al.  Perfusion Imaging in Neuro-Oncology: Basic Techniques and Clinical Applications. , 2016, Magnetic resonance imaging clinics of North America.

[25]  K. Wei,et al.  Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas , 2016, Scientific Reports.

[26]  M. Weller,et al.  EANO guidelines for the diagnosis and treatment of meningiomas. , 2016, The Lancet. Oncology.

[27]  A. Buck,et al.  68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate? , 2016, Neuro-oncology.

[28]  Z. Cho,et al.  Experience with 7.0 T MRI in Patients with Supratentorial Meningiomas , 2016, Journal of Korean Neurosurgical Society.

[29]  J. Hainsworth,et al.  A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma , 2016, Journal of Neuro-Oncology.

[30]  J. Farah,et al.  Early adjuvant radiotherapy in the treatment of atypical meningioma , 2016, Journal of Clinical Neuroscience.

[31]  T. Huber,et al.  Patterns and Time Dependence of Unspecific Enhancement in Postoperative Magnetic Resonance Imaging After Glioblastoma Resection. , 2016, World neurosurgery.

[32]  T. Jiang,et al.  Correlations of magnetic resonance, perfusion-weighed imaging parameters and microvessel density in meningioma. , 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[33]  Jörg-Christian Tonn,et al.  Orbit-associated tumors: navigation and control of resection using intraoperative computed tomography. , 2016, Journal of neurosurgery.

[34]  M. Weller,et al.  Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake. , 2016, Neuro-oncology.

[35]  O. Boyko,et al.  Predicting Meningioma Consistency on Preoperative Neuroimaging Studies. , 2016, Neurosurgery clinics of North America.

[36]  Thomas C Chen Primary Intraosseous Meningioma. , 2016, Neurosurgery clinics of North America.

[37]  M. Shiroishi,et al.  Advanced Imaging of Intracranial Meningiomas. , 2016, Neurosurgery clinics of North America.

[38]  M. Weller,et al.  Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma. , 2016, Neuro-oncology.

[39]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[40]  A. Niemierko,et al.  Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. , 2015, Neuro-oncology.

[41]  K. Aldape,et al.  Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas. , 2016, Journal of neurosurgery.

[42]  T. Mathiesen The quality of articles and challenges ahead , 2016, Acta Neurochirurgica.

[43]  U. Roelcke,et al.  Susceptibility changes in meningiomas influence the apparent diffusion coefficient in diffusion-weighted MRI. , 2015, Journal of neuroradiology. Journal de neuroradiologie.

[44]  A. Wienke,et al.  Diffusion-Weighted Imaging in Meningioma: Prediction of Tumor Grade and Association with Histopathological Parameters12 , 2015, Translational oncology.

[45]  Richard Ehman,et al.  Higher-Resolution Magnetic Resonance Elastography in Meningiomas to Determine Intratumoral Consistency. , 2015, Neurosurgery.

[46]  S. Mukundan,et al.  Utility of dynamic computed tomography angiography in the preoperative evaluation of skull base tumors. , 2015, Journal of neurosurgery.

[47]  R. Tarnawski,et al.  The Use of 68Ga-DOTA-(Tyr3)-Octreotate PET/CT for Improved Target Definition in Radiotherapy Treatment Planning of Meningiomas - A Case Report. , 2015, Current radiopharmaceuticals.

[48]  Jun Pan,et al.  Preoperative Radiologic Classification of Convexity Meningioma to Predict the Survival and Aggressive Meningioma Behavior , 2015, PloS one.

[49]  U. Schüller,et al.  Increased 68Ga-DOTATATE Uptake in PET Imaging Discriminates Meningioma and Tumor-Free Tissue , 2015, The Journal of Nuclear Medicine.

[50]  M. Briel,et al.  Somatostatin Receptor–Targeted Radiopeptide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial , 2015, The Journal of Nuclear Medicine.

[51]  M. Kataoka,et al.  Grading Meningioma , 2015, Medicine.

[52]  A. Haug,et al.  Ga-68-DOTA-TATE PET/CT for Discrimination of Tumors of the Optic Pathway , 2015, Orbit.

[53]  Jill S. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 , 2015, Neuro-oncology.

[54]  H. Sakahara,et al.  Pseudo-continuous arterial spin labeling reflects vascular density and differentiates angiomatous meningiomas from non-angiomatous meningiomas , 2015, Journal of Neuro-Oncology.

[55]  M. Feychting,et al.  Long-term follow-up of incidentally discovered meningiomas , 2015, Acta Neurochirurgica.

[56]  E. Hattingen,et al.  Time window for postoperative reactive enhancement after resection of brain tumors: less than 72 hours. , 2014, Neurosurgical focus.

[57]  R. Prayson,et al.  Dural-based Rosai–Dorfman disease: Differential diagnostic considerations , 2014, Journal of Clinical Neuroscience.

[58]  Hung-Wen Kao,et al.  Correlation between magnetic resonance imaging grading and pathological grading in meningioma. , 2014, Journal of neurosurgery.

[59]  Shin Jung,et al.  Immunohistochemical profile of the dural tail in intracranial meningiomas , 2014, Acta Neurochirurgica.

[60]  Y. Mao,et al.  Diffusion tensor magnetic resonance imaging for predicting the consistency of intracranial meningiomas , 2014, Acta Neurochirurgica.

[61]  D. Takhtani,et al.  Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma. , 2014, AJR. American journal of roentgenology.

[62]  Jian-Rong Xu,et al.  Usefulness of Dual-Energy Computed Tomography Imaging in the Differential Diagnosis of Sellar Meningiomas and Pituitary Adenomas: Preliminary Report , 2014, PloS one.

[63]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[64]  K. Langen,et al.  68Ga-DOTATATE-positron emission tomography imaging in spinal meningioma , 2014, Journal of craniovertebral junction & spine.

[65]  F. Yamasaki,et al.  Preoperative histological grading of meningiomas using apparent diffusion coefficient at 3T MRI. , 2013, European journal of radiology.

[66]  Armando Manduca,et al.  Preoperative assessment of meningioma stiffness using magnetic resonance elastography. , 2013, Journal of neurosurgery.

[67]  Feng-ping Huang,et al.  Histopathological classification and location of consecutively operated meningiomas at a single institution in China from 2001 to 2010. , 2013, Chinese medical journal.

[68]  I. Steffen,et al.  Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy. , 2013, International journal of radiation oncology, biology, physics.

[69]  B. Yin,et al.  Correlating apparent diffusion coefficients with histopathologic findings on meningiomas. , 2012, European journal of radiology.

[70]  Figen Soylemezoglu,et al.  Is diffusion-weighted imaging useful in grading and differentiating histopathological subtypes of meningiomas? , 2012, European journal of radiology.

[71]  P. Schaefer,et al.  Correlation between dynamic contrast-enhanced perfusion MRI relative cerebral blood volume and vascular endothelial growth factor expression in meningiomas. , 2012, Academic radiology.

[72]  U. Haberkorn,et al.  Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET/CT and contrast-enhanced MRI , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[73]  R. McLendon,et al.  Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series , 2012, Journal of Neuro-Oncology.

[74]  R. Sweeney,et al.  PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[75]  H. Kishima,et al.  Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. , 2012, Journal of Neurosurgery.

[76]  Mitsutoshi Nakada,et al.  Prediction of high-grade meningioma by preoperative MRI assessment , 2012, Journal of Neuro-Oncology.

[77]  John Y. K. Lee,et al.  Determination of grade and subtype of meningiomas by using histogram analysis of diffusion-tensor imaging metrics. , 2012, Radiology.

[78]  R. Jain,et al.  Computer-aided volumetric analysis as a sensitive tool for the management of incidental meningiomas , 2012, Acta Neurochirurgica.

[79]  I. Tsougos,et al.  Distinct peak at 3.8 ppm observed by 3T MR spectroscopy in meningiomas, while nearly absent in high-grade gliomas and cerebral metastases , 2012, Molecular medicine reports.

[80]  T. Watabe,et al.  Clinical characteristics of meningiomas assessed by 11C-methionine and 18F-fluorodeoxyglucose positron-emission tomography , 2012, Journal of Neuro-Oncology.

[81]  Fredric B. Meyer,et al.  Use of preoperative magnetic resonance imaging T1 and T2 sequences to determine intraoperative meningioma consistency , 2011, Surgical neurology international.

[82]  J. Tonn,et al.  Molecular imaging of gliomas with PET: opportunities and limitations. , 2011, Neuro-oncology.

[83]  Matthias Briel,et al.  Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  S. Oya,et al.  The natural history of intracranial meningiomas. , 2011, Journal of neurosurgery.

[85]  M. Berger,et al.  Results with judicious modern neurosurgical management of parasagittal and falcine meningiomas. Clinical article. , 2011, Journal of neurosurgery.

[86]  J. Liu Results with judicious modern neurosurgical management of parasagittal and falcine meningiomas , 2011 .

[87]  J. Jito,et al.  Growth curve analysis of asymptomatic and symptomatic meningiomas , 2011, Journal of Neuro-Oncology.

[88]  D. Ginat,et al.  Correlation of diffusion and perfusion MRI with Ki-67 in high-grade meningiomas. , 2010, AJR. American journal of roentgenology.

[89]  M. McDermott,et al.  Treatment decision making based on the published natural history and growth rate of small meningiomas. , 2010, Journal of neurosurgery.

[90]  T. Huisman Diffusion-weighted and diffusion tensor imaging of the brain, made easy , 2010, Cancer imaging : the official publication of the International Cancer Imaging Society.

[91]  D. Long,et al.  Perioperative and Long-term Outcomes From the Management of Parasagittal Meningiomas Invading the Superior Sagittal Sinus , 2010, Neurosurgery.

[92]  R. Scienza,et al.  Diffusion-weighted imaging does not predict histological grading in meningiomas , 2010, Acta Neurochirurgica.

[93]  C. Belka,et al.  [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning , 2009, Radiation oncology.

[94]  Ting-Yim Lee,et al.  Theoretic Basis and Technical Implementations of CT Perfusion in Acute Ischemic Stroke, Part 2: Technical Implementations , 2009, American Journal of Neuroradiology.

[95]  Jeong Won Lee,et al.  18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[96]  Naoki Kagawa,et al.  Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. , 2009, Journal of neurosurgery.

[97]  M. Cremonesi,et al.  Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[98]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[99]  S. Ng,et al.  Differentiation Between Classic and Atypical Meningiomas with Use of Diffusion Tensor Imaging , 2008, American Journal of Neuroradiology.

[100]  C. Lim,et al.  DIFFUSION TENSOR TRACTOGRAPHY: CORTICOSPINAL TRACT FIBER REDUCTION IS ASSOCIATED WITH TEMPORARY HEMIPARESIS IN BENIGN EXTRACEREBRAL LESIONS , 2008, Neurosurgery.

[101]  Y.H. Chan,et al.  Diffusion-Weighted MR Imaging: Diagnosing Atypical or Malignant Meningiomas and Detecting Tumor Dedifferentiation , 2008, American Journal of Neuroradiology.

[102]  E. Krenning,et al.  Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[103]  W. Joo,et al.  Peritumoral brain edema in meningiomas: correlations between magnetic resonance imaging, angiography, and pathology. , 2008, Surgical neurology.

[104]  Matthijs Oudkerk,et al.  Perfusion MR imaging for differentiation of benign and malignant meningiomas , 2008, Neuroradiology.

[105]  M. Radoš,et al.  Characteristics of typical and atypical meningiomas on ADC maps with respect to schwannomas. , 2008, Clinical imaging.

[106]  C. Alafaci,et al.  Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density? , 2008, Oncology reports.

[107]  R. Mrak,et al.  Management of bone-invasive, hyperostotic sphenoid wing meningiomas. , 2007, Journal of neurosurgery.

[108]  W M Adams,et al.  Atypical imaging appearances of intracranial meningiomas. , 2007, Clinical radiology.

[109]  H. Chang,et al.  FDG PET/CT Assessment of the Biological Behavior of Meningiomas , 2006 .

[110]  A. Dinçer,et al.  Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. , 2006, European journal of radiology.

[111]  T. Hori,et al.  Clinical and radiological features related to the growth potential of meningioma , 2006, Neurosurgical Review.

[112]  Bahattin Hakyemez,et al.  Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation? , 2006, Neuroradiology.

[113]  B. Hakyemez,et al.  The contribution of diffusion-weighted MR imaging to distinguishing typical from atypical meningiomas , 2006, Neuroradiology.

[114]  T. Yoshimine,et al.  Scoring radiologic characteristics to predict proliferative potential in meningiomas , 2006, Brain Tumor Pathology.

[115]  H. Itoh,et al.  Perfusion imaging of meningioma by using continuous arterial spin-labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features. , 2006, AJNR. American journal of neuroradiology.

[116]  Kaoru Kurisu,et al.  Apparent diffusion coefficient of human brain tumors at MR imaging. , 2005, Radiology.

[117]  S. Nakasu,et al.  Growth Pattern Changes of Meningiomas: Long-term Analysis , 2005, Neurosurgery.

[118]  M. Samii,et al.  Volumetric Analysis of the Growth Rate of Incompletely Resected Intracranial Meningiomas , 2005, Zentralblatt fur Neurochirurgie.

[119]  Glyn Johnson,et al.  Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. , 2003, AJNR. American journal of neuroradiology.

[120]  Madjid Samii,et al.  The Natural History of Incidental Meningiomas , 2003, Neurosurgery.

[121]  Glyn Johnson,et al.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. , 2002, Radiology.

[122]  W. Wong,et al.  Positron emission tomography (PET)--evaluation of 'indeterminate pulmonary lesions'. , 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

[123]  Jia-Hong Gao,et al.  Perfusion MRI Evaluation of Correlating Perfusion Constants with Histologic Findings in Meningiomas , 2002 .

[124]  T. Tamiya,et al.  Peritumoral Brain Edema in Intracranial Meningiomas: Effects of Radiological and Histological Factors , 2001, Neurosurgery.

[125]  M A Edgar,et al.  Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. , 2001, AJNR. American journal of neuroradiology.

[126]  G. Fuller,et al.  Primary extradural meningiomas: a report on nine cases and review of the literature from the era of computerized tomography scanning. , 2000, Journal of neurosurgery.

[127]  Y. Iwadate,et al.  Glucose and methionine uptake and proliferative activity in meningiomas. , 1999, Neurological research.

[128]  K. Sugiyama,et al.  Peritumoral brain edema associated with meningioma , 1999, Cancer.

[129]  吉岡 宏幸 Peritumoral brain edema in associated with meningioma : Influence of vascular endothelial growth factor expression and vascular blood supply , 1999 .

[130]  U. Kumar,et al.  Expression of somatostatin receptor subtypes in human brain tumors , 1998, International journal of cancer.

[131]  B. Scheithauer,et al.  Meningioma grading: an analysis of histologic parameters. , 1997, The American journal of surgical pathology.

[132]  J. Gilsbach,et al.  Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[133]  S. Nakasu,et al.  Meningioma: proliferating potential and clinicoradiological features. , 1995, Neurosurgery.

[134]  G. Hounsfield Computerized transverse axial scanning (tomography): Part I. Description of system. 1973. , 1973, The British journal of radiology.

[135]  K. Sartor,et al.  Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. , 1995, Neurosurgery.

[136]  A. Mahmood,et al.  Atypical and malignant meningiomas: a clinicopathological review. , 1993 .

[137]  S. Howng,et al.  Intracranial meningioma. , 1992, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences.

[138]  A. Osborn,et al.  Intracranial meningioma. , 1992, AJNR. American journal of neuroradiology.

[139]  J. Smirniotopoulos,et al.  Typical, atypical, and misleading features in meningioma. , 1991, Radiographics : a review publication of the Radiological Society of North America, Inc.

[140]  S. Aoki,et al.  Contrast-enhanced MR images in patients with meningioma: importance of enhancement of the dura adjacent to the tumor. , 1990, AJNR. American journal of neuroradiology.

[141]  T. Cascino,et al.  Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[142]  K. Go,et al.  Peritumoral brain edema associated with meningiomas. , 1988, Neurosurgery.

[143]  G. di Chiro,et al.  Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. , 1987, Radiology.

[144]  J. Jääskeläinen,et al.  The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. , 1985, Surgical Neurology.

[145]  H. Nakagawa,et al.  Multiple meningiomas evaluated by computed tomography. , 1981, Neurosurgery.

[146]  A. George,et al.  Atypical computed tomography features of intracranial meningioma: radiological-pathological correlation in a series of 131 consecutive cases. , 1980, Radiology.

[147]  P. Lauterbur,et al.  Image Formation by Induced Local Interactions: Examples Employing Nuclear Magnetic Resonance , 1973, Nature.

[148]  D. Simpson THE RECURRENCE OF INTRACRANIAL MENINGIOMAS AFTER SURGICAL TREATMENT , 1957, Journal of neurology, neurosurgery, and psychiatry.

[149]  F. Hodges,et al.  Differential diagnosis of intracranial neoplasms by cerebral angiography. , 1947, Radiology.